UCB Announces U.S. Availability Of BIMZELX To Treat Adults With Moderate-to-Severe Plaque Psoriasis

RTTNews | 622 dias atrás
Stocktwits
UCB Announces U.S. Availability Of BIMZELX To Treat Adults With Moderate-to-Severe Plaque Psoriasis

(RTTNews) - Biopharmaceutical company UCB (UCB) announced Tuesday the commercial availability of BIMZELX in the United States for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

BIMZELX was approved by the U.S. Food and Drug Administration (FDA) on October 17, 2023. It is the first and only IL-17A and IL-17F inhibitor approved for the treatment of adults with moderate-to-severe plaque psoriasis.

BIMZELX is available as an autoinjector and a pre-filled syringe and it may be administered subcutaneously by a healthcare professional, or a patient may self-inject after proper training.

BIMZELX is the first and only approved psoriasis treatment designed to selectively inhibit two key cytokines driving inflammatory processes - interleukin 17A (IL-17A) and interleukin 17F (IL-17F).

The approval of BIMZELX is supported by data from three Phase 3, multicenter, randomized, placebo and/or active comparator-controlled trials (BE READY, BE VIVID, and BE SURE), which evaluated the efficacy and safety of BIMZELX in 1,480 adults with moderate-to-severe plaque psoriasis.

Marcadores : UCB
Stocktwits
read more
Swiss Stocks Slip On Late Selling; SMI Ends 0.34% Down

Swiss Stocks Slip On Late Selling; SMI Ends 0.34% Down

The Switzerland market closed weak on Monday as a few stocks tumbled on selling pressure in the final hour of the day's session. The market got off to a firm start, in line with markets across Europe, as news about the U.S. and European Union agreed on a trade deal over the weekend. However, the mood turned cautious as the day progressed, and the market eventually closed on a weak note.
RTTNews | 1h 56min atrás
European Markets Fail To Hold Gains, Settle Weak

European Markets Fail To Hold Gains, Settle Weak

Despite opening on a bright note, European stocks retreated and settled mostly lower on Monday, as initial buoyancy over an EU-US trade deal faded and investors looked ahead to earnings updates, some crucial economic data and policy announcements from the Federal Reserve and the Bank of Japan this week.
RTTNews | 2h 22min atrás
Canadian Market Modestly Lower; Materials Stocks Decline

Canadian Market Modestly Lower; Materials Stocks Decline

Despite the U.S.-European Union agreeing on a trade deal over the weekend, the mood in the market remains cautious. The market slipped after opening flat Monday morning, and despite staging a recovery subsequently, remains in negative territory, weighed down by losses in materials sector due to weak metal prices.
RTTNews | 3h 35min atrás
Tesla, Samsung Sign $16.54 Bln Chip Deal; Shares Gain

Tesla, Samsung Sign $16.54 Bln Chip Deal; Shares Gain

EV major Tesla Inc. and South Korean chip maker Samsung Electronics Co. Ltd. have entered into a contract worth around 22.76 trillion Korean Won or $16.54 billion for semiconductor contract manufacturing. Tesla founder and CEO Elon Musk in a post on the social media platform confirmed that Samsung will be making Tesla's next-generation AI6 chip.
RTTNews | 5h 45min atrás
Bay Street Likely To Open Higher

Bay Street Likely To Open Higher

Canadian shares may open on a positive note Monday morning following the U.S. and European Union agreeing on a trade deal.
RTTNews | 7h 2min atrás
FTSE 100 Retreats After Positive Start, Down Marginally

FTSE 100 Retreats After Positive Start, Down Marginally

The U.K. market is down slightly a little past noon on Monday, having shed early gains, as investors await a slew of corporate earnings announcements due this week. Reports about the EU and U.S. arriving at a trade deal lifted sentiment in European markets this morning, but most of the major markets are off early highs with the focus shifting to earnings and economic data.
RTTNews | 8h 1min atrás
Ferramentas
Calendário Econômico
Horário do mercado
Taxas de juros
Calendário de feriados
Mercado Forex
Volatilidade no Forex
Correlação no Forex
Notícias sobre Forex
forex analysis
Dados do COT
Liquidez
Calculadoras Forex
Mapa do Calor do Forex
Mapa de calor de indicadores
Comunidade
Comunidade
Sistemas
Sistemas Mais Populares
Estratégias
Concursos
Gráficos de Forex
Sentimento do Forex
Indicador de Perspectivas
Análises
Corretoras
Prop Trading Firms
Serviços de VPS
Provedores de Sinais
Serviços de Programação de EA
Affiliate Programs
Serviços de Corretora PAMM
Serviços de Programa de Reembolso
Plataformas de Trading
Expert Advisors
Exchanges de Criptomoedas
Trading Courses
Corretoras
Spreads das Corretoras de Forex
Cotações de Corretoras de Forex
Swaps de Corretoras de Forex
Volume da Corretora de Forex
Promoções de Corretoras de Forex Comunicado De Imprensa
Plataforma
Widgets
Recursos
API
RSS
Stock Portfolio
Affiliate Software
Gráficos Avançados
Assistência
Perguntas Frequentes
Ajuda
Entre em contato conosco
Relatar um erro!
Sobre
Blog
© 2025 Myfxbook Ltd. Todos os Direitos Reservados.
AVISO DE ALTO RISCO: A negociação no mercado de câmbio traz consigo um alto nível de risco que pode não ser adequado para qualquer investidor. A alavancagem cria exposição adicional a riscos e perdas. Antes de decidir negociar no mercado de câmbio, considere cuidadosamente seus objetivos de investimento, seu nível de experiência e sua tolerância ao risco. Você pode perder parte de seu investimento inicial ou todo ele. Não invista um dinheiro que você não tem condições de perder. Informe-se sobre os riscos associados à negociação no mercado de câmbio e procure o conselho de um consultor financeiro ou fiscal independente, caso tenha alguma dúvida. Quaisquer dados e informações são fornecidos "como estão" exclusivamente para fins informativos. Eles não se destinam a fins comerciais ou de aconselhamento. O desempenho passado não é indicativo de resultados futuros.